F45.41
Conditions
Interventions
Group 1: Patients with chronic non-tumor pain who have been continuously prescribed cannabinoids by their treating physicians for at least two years
Group 2: Patients with chronic non-tumor pain who h
Sponsors
Klinik für Anästhesiologie Universitätsklinikum Heidelberg - Sektion Schmerzmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with chronic non-tumor pain, at least two years of continuous cannabinoid therapy or discontinuation of cannabinoid therapy after a maximum of 6 months; therapy costs covered by the respective health insurance company
Exclusion criteria
Exclusion criteria: Patient refusal to participate in the study, lack of consent, patients not legally capable of giving consent, insufficient understanding of the German language, patients under 18 years of age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study aims to explore which psychosocial factors contribute to a response to treatment with cannabinoid medication in patients with chronic non-tumor pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| In addition, a contrast should be made between patients with long-term treatment with cannabinoid medication for at least two years and those who discontinue treatment (short-term, maximum six-month treatment). | — |
Countries
Germany
Contacts
Public ContactMarco Richard Zugaj
Klinik für Anästhesiologie Universitätsklinikum Heidelberg - Sektion Schmerzmedizin
Outcome results
None listed